Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition.
Saved in:
| Title: | Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition. |
|---|---|
| Authors: | Hurcombe JA; Bristol Renal, University of Bristol, Bristol, UK., Barrington F; Bristol Renal, University of Bristol, Bristol, UK., Marchetti M; Bristol Renal, University of Bristol, Bristol, UK., Betin VMS; Bristol Renal, University of Bristol, Bristol, UK., Bowen EE; Bristol Renal, University of Bristol, Bristol, UK., Lay AC; Bristol Renal, University of Bristol, Bristol, UK., Ni L; Bristol Renal, University of Bristol, Bristol, UK., Dayalan L; Bristol Renal, University of Bristol, Bristol, UK., Pope RJP; Bristol Renal, University of Bristol, Bristol, UK., Brinkkoetter PT; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Holzenberger M; Sorbonne University, INSERM, Paris, France., Welsh GI; Bristol Renal, University of Bristol, Bristol, UK., Coward RJM; Bristol Renal, University of Bristol, Bristol, UK. |
| Source: | IScience [iScience] 2024 Apr 16; Vol. 27 (5), pp. 109749. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
